Connor, Clark & Lunn Investment Management Ltd.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1596800
VANCOUVER, A1
Position in NBIX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$20,255,683
-$14,675,485 QoQ
Shares Held
153,755
-37.6% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $83,482,045 across 14 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
572,598 | $36,617,642 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
721,002 | $12,949,195 | |
| 3 | ZTS |
Zoetis Inc.
|
118,491 | $8,514,763 | |
| 4 | IRWD |
Ironwood Pharmaceuticals Inc
|
1,811,714 | $7,627,315 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
192,766 | $6,530,911 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
231,979 | $3,361,375 | |
| 7 | EBS |
Emergent BioSolutions Inc.
|
353,983 | $2,966,377 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
95,381 | $2,347,326 |
All Filings in NBIX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,255,683 | 153,755 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $34,931,168 | 246,289 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $39,462,642 | 281,113 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $31,250,681 | 248,633 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $6,178,669 | 55,865 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $8,678,943 | 63,582 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,980,170 | 17,186 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $307,004 | 2,230 | Shares | Sole | 2024-08-09 | |
| 2023-12-31 | $3,678,870 | 27,921 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $7,882,762 | 70,069 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $15,301,966 | 162,269 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $24,415,883 | 241,216 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $21,093,581 | 176,604 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $20,956,082 | 197,308 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $20,928,663 | 214,697 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $19,649,906 | 209,599 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,436,249 | 52,087 | Shares | Sole | 2022-02-10 | |
| 2021-03-31 | $445,988 | 4,586 | Shares | Sole | 2021-05-13 | |
| 2020-09-30 | $1,009,583 | 10,499 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||